Glaxosmithkline Plc (GSK)
$43.49 0.06 (0.14%)
19:41 EST GSK Stock Quote Delayed 15 Minutes
Previous Close $43.49
Market Cap 107.84B
PE Ratio 104.54
Volume (Avg. Vol.) 3.54M
Day's Range 43.48 - 43.79
52-Week Range 38.43 - 48.25
Dividend & Yield 2.14 (4.92%)
GSK Stock Predictions, Articles, and Glaxosmithkline Plc News
- From InvestorPlace
- From the Web
Amarin is targeting a huge market, and its main drug -- Vascepa -- is likely to be expanded in its coverage. Here’s a look at what’s ahead for the stock.
Turning Point Brands, Cronos Group and Altria are just some of the stocks to buy or sell here at a pivotal time for vaporizers.
With international dividend stocks, valuations are generally better and yields are bigger. Here are five stocks that stand out.
These ten stocks aren't exactly household names, but they each deserve a spot in a list of small-cap stocks to buy now for traders that can deal with the risk for the potential of high reward.
Think all blue-chip stocks are safe buys at any time? Think again. These companies may be about to stumble, if they haven't already.
These three biopharma stocks to buy should help investors maintain strength amid any potential chaos in 2019.
GlaxoSmithKline (GSK) stock is up today on news of a new joint venture with Pfizer (PFE) for a consumer healthcare business.
The stock charts of ROST, D and MS are shaping up as the top trading prospects as December's action gets going.
Tesaro stock was flying high on Monday with news that GlaxoSmithKline (GSK) is planning to acquire it in a deal worth $5.10 billion.
If you're looking for the best dividend stocks with high yields and solid growth prospects, don't limit yourself -- look overseas.
These seven healthcare stocks are coming to life Monday. Here's how to play these companies without getting burnt.
GlaxoSmithKline pays shareholders a solid dividend yet the company is not just for income investors. In the next few years, growth in the consumer unit will lead to strong cash flow, raising the chances of dividend hikes for GSK stock.
Small-cap stocks have been on a tear of late. Take the hint, and start your search with these seven top prospects.
International dividend stocks should make up a hefty portion of your portfolio, as you need them to smooth out the sort of stateside volatility we're experiencing right now.
In the first six months of the year, the FDA grants approval to 17 new treatments. Compare Brokers....
Though the large-cap pharma industry is struggling currently, there are a few stocks that are performing well. Compare Brokers....
The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.
GlaxoSmithKline (GSK) stock was down on Wednesday following the release of an earnings report that misses estimates for the first quarter of 2018.
Often there are signs leading up to dividend stocks cutting their payouts. If you own any of these 7 you'd be better off moving your money elsewhere.
From Seeking Alpha
Navellier RatingsPowered by Portfolio Grader